✦ LIBER ✦

Tu1199 Predictors of Loss of Response to IFX Maintenance Therapy in Pediatric-Onset Crohn's Disease

✍ Scribed by Dupont-Lucas, Claire; Sternszus, Robert; Ezri, Jessica; Amre, Devendra K.; Leibovitch, Samantha; Deslandres, Colette

Book ID: 122174740
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 503 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)62820-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of Treatment Response to Infliximab

Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective

✍ Eric Qiong Wu; Parvez M. Mulani; Andrew Peng Yu; Jackson Tang; Paul F. Pollack 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Tu1148 Mechanisms of Loss of Response to

Tu1148 Mechanisms of Loss of Response to Adalimumab in Crohn's Disease

✍ Wolf, Douglas C.; Hauenstein, Scott; Lockton, Steven; Singh, Sharat 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Su1126 In Patients With Crohn's Disease,

Su1126 In Patients With Crohn's Disease, Concomitant Enteral Nutrition Reduces the Loss of Response to Adalimumab Maintenance Therapy

✍ Yoshimura, Naoki; Kawaguchi, Takaaki; Sako, Minako; Saniabadi, Abbi; Takazoe, Ma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Su1225 Concomitant Elemental Diet Therap

Su1225 Concomitant Elemental Diet Therapy Is Effective in Sustaining Infliximab Scheduled Maintenance Therapy in Patients With Crohn's Disease to Prevent Loss of Response

✍ Kamata, Noriko; Watanabe, Kenji; Tsukahara, Takuya; Hagihara, Yoshie; Morimoto, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy of infliximab in pediatric Croh

Efficacy of infliximab in pediatric Crohn's disease: A randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy

✍ Frank M. Ruemmele; Alain Lachaux; Jean-Pierre Cézard; Alain Morali; Chantal Maur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is efficacious in inducing remission in severe forms of pediatric crohn's disease (cd). adult studies indicate that ifx is also safe and well tolerated as maintenance therapy. the present study aimed to evaluate in a prospective manner the efficacy and safety of ifx

Tu1944 Efficacy and Safety of Standard v

Tu1944 Efficacy and Safety of Standard vs Low Dose Adalimumab Maintenance Therapy As a Function of Disease Severity in Pediatric Patients With Crohn's Disease: Subanalysis of Imagine 1

✍ Hyams, Jeffrey S.; Crandall, Wallace; Rosh, Joel R.; Ruemmele, Frank; Escher, Jo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 258 KB